spiroxatrine
| SMILES | O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 |
| InChIKey | JVGBTTIJPBFLTE-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 5 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 3 |
| Molecular weight (Da) | 379.2 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 8.8 | 8.8 | 8.8 | Guide to Pharmacology |
| 5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 6.3 | 6.55 | 6.8 | Guide to Pharmacology |
| α1A | ADA1A | Human | Adrenoceptors | A | pKi | 6.9 | 7.1 | 7.3 | Guide to Pharmacology |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 7.6 | 7.6 | 7.6 | Guide to Pharmacology |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 7.9 | 7.9 | 7.9 | Guide to Pharmacology |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 7.0 | 7.15 | 7.3 | Guide to Pharmacology |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 7.9 | 8.35 | 8.8 | Guide to Pharmacology |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.7 | 8.85 | 9.0 | Guide to Pharmacology |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 6.5 | 6.5 | 6.5 | ChEMBL |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 6.86 | 6.86 | 6.86 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 7.97 | 7.97 | 7.97 | ChEMBL |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.07 | 8.07 | 8.07 | ChEMBL |
| 5-HT7 | 5HT7R | Human | 5-Hydroxytryptamine | A | pKi | 7.18 | 7.18 | 7.18 | ChEMBL |
| D2 | DRD2 | Rat | Dopamine | A | pKi | 8.84 | 9.25 | 9.66 | ChEMBL |
| 5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pKi | 7.68 | 8.2 | 8.72 | ChEMBL |
| D4 | DRD4 | Human | Dopamine | A | pKi | 7.71 | 7.71 | 7.71 | ChEMBL |
| α1A | ADA1A | Human | Adrenoceptors | A | pKi | 6.35 | 6.35 | 6.35 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 6.21 | 6.21 | 6.21 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKd | 8.6 | 8.6 | 8.6 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 7.25 | 7.25 | 7.25 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pKi | 8.11 | 8.11 | 8.11 | ChEMBL |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.15 | 6.15 | 6.15 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pKi | 6.15 | 6.15 | 6.15 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pKi | 7.89 | 7.89 | 7.89 | ChEMBL |
| D2 | DRD2 | Human | Dopamine | A | pKi | 8.17 | 8.17 | 8.17 | ChEMBL |
| 5-HT5A | 5HT5A | Human | 5-Hydroxytryptamine | A | pKi | 5.42 | 5.42 | 5.42 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| NOP | OPRX | Human | Opioid | A | pEC50 | 6.49 | 6.49 | 6.49 | ChEMBL |